These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37492687)

  • 1. Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.
    Malik DG; Rath TJ; Urcuyo Acevedo JC; Canoll PD; Swanson KR; Boxerman JL; Quarles CC; Schmainda KM; Burns TC; Hu LS
    Front Radiol; 2022; 2():809373. PubMed ID: 37492687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade glioma management and response assessment-recent advances and current challenges.
    Khan MN; Sharma AM; Pitz M; Loewen SK; Quon H; Poulin A; Essig M
    Curr Oncol; 2016 Aug; 23(4):e383-91. PubMed ID: 27536188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.
    Flies CM; van Leuken KH; Ten Voorde M; Verhoeff JJC; De Vos FYF; Seute T; Robe PA; Witkamp TD; Hendrikse J; Dankbaar JW; Snijders TJ
    Neurology; 2022 Jul; 99(1):e77-e88. PubMed ID: 35437259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study.
    Dagher SA; Liu HL; Ozkara BB; Calle S; Kaya D; Gule-Monroe MK; Chasen NN; Schellingerhout D; Learned KO; Shah KB; Johnson JM; Sun J; Schomer DF; Kumar VA; Wintermark M; Majd NK; Nam JY; Chen MM
    AJR Am J Roentgenol; 2024 Aug; ():. PubMed ID: 39140632
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities.
    Tran DK; Jensen RL
    Surg Neurol Int; 2013; 4(Suppl 3):S129-35. PubMed ID: 23682339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review.
    Sidibe I; Tensaouti F; Roques M; Cohen-Jonathan-Moyal E; Laprie A
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma:
    Hu LS; Smits M; Kaufmann TJ; Knutsson L; Rapalino O; Galldiks N; Sundgrene PC; Cha S
    AJR Am J Roentgenol; 2024 Mar; ():. PubMed ID: 38477525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion basis spectrum imaging as an adjunct to conventional MRI leads to earlier diagnosis of high-grade glioma tumor progression versus treatment effect.
    Han RH; Johanns TM; Roberts KF; Tao Y; Luo J; Ye Z; Sun P; Blum J; Lin TH; Song SK; Kim AH
    Neurooncol Adv; 2023; 5(1):vdad050. PubMed ID: 37215950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.
    Zikou A; Sioka C; Alexiou GA; Fotopoulos A; Voulgaris S; Argyropoulou MI
    Contrast Media Mol Imaging; 2018; 2018():6828396. PubMed ID: 30627060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the glioma microvasculature: a case series of the comparison between perfusion MRI and intraoperative high-frame-rate ultrafast Doppler ultrasound.
    Alafandi A; Tbalvandany SS; Arzanforoosh F; van Der Voort SR; Incekara F; Verhoef L; Warnert EAH; Kruizinga P; Smits M
    Eur Radiol Exp; 2024 Jan; 8(1):13. PubMed ID: 38273190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers.
    Le Fèvre C; Constans JM; Chambrelant I; Antoni D; Bund C; Leroy-Freschini B; Schott R; Cebula H; Noël G
    Crit Rev Oncol Hematol; 2021 Mar; 159():103230. PubMed ID: 33515701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?
    Shah AH; Snelling B; Bregy A; Patel PR; Tememe D; Bhatia R; Sklar E; Komotar RJ
    J Neurooncol; 2013 Apr; 112(2):141-52. PubMed ID: 23344789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
    Shiroishi MS; Boxerman JL; Pope WB
    Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients.
    Yoo RE; Choi SH
    Magn Reson Med Sci; 2016; 15(2):165-77. PubMed ID: 26726012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
    Abbasi AW; Westerlaan HE; Holtman GA; Aden KM; van Laar PJ; van der Hoorn A
    Clin Neuroradiol; 2018 Sep; 28(3):401-411. PubMed ID: 28466127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.
    Nyberg E; Honce J; Kleinschmidt-DeMasters BK; Shukri B; Kreidler S; Nagae L
    Neuroradiol J; 2016 Oct; 29(5):377-83. PubMed ID: 27542895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.